EOPA Arterial Cannula, Model Numbers 77422 (22 Fr) and 77418 (18 Fr) Recall
EOPA Arterial Cannula, Model Numbers 77422 (22 Fr) and 77418 (18 Fr)
FDA recall Class II
Ongoing
FDA lists this Class II recall for EOPA Arterial Cannula, Model Numbers 77422 (22 Fr) and 77418 (18 Fr). Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0985-2025
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Dec 12, 2024
- FDA report date
- Jan 29, 2025
- Quantity in commerce
- 930 units
- Distribution
- See key details
- FDA cause
- Packaging
What is being recalled?
EOPA Arterial Cannula, Model Numbers 77422 (22 Fr) and 77418 (18 Fr)
Affected model & UDI checker
Search the exact identifiers published for Z-0985-2025.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| 77418 | EOPA Arterial Cannula, Model Numbers 77422 (22 Fr) and 77418 (18 Fr) | Check source notice | Not specified |
| 77422 | EOPA Arterial Cannula, Model Numbers 77422 (22 Fr) and 77418 (18 Fr) | Check source notice | Not specified |
| Not specified | EOPA Arterial Cannula, Model Numbers 77422 (22 Fr) and 77418 (18 Fr) | Check source notice | 20763000135618 |
| Not specified | EOPA Arterial Cannula, Model Numbers 77422 (22 Fr) and 77418 (18 Fr) | Check source notice | 20643169485970 |
FDA code information
Model 77418 UDI-DI: 20763000135618, Lot Numbers: 2022041038; Model 77422 UDI-DI: 20643169485970, Lot Number: 2023020934
Why was this product recalled?
Incorrect labeling for seven manufactured lots of certain models of Arterial Cannulae.
What actions did MEDTRONIC PERFUSION SYSTEMS take?
An URGENT: MEDICAL DEVICE RECALL notification letter dated 12/12/24 was sent to customers. Patient Recommendations: Patients previously supported with an impacted device face no additional risk from the issue described in this communication and should continue to be monitored per your practice s normal follow-up procedures. Customer Actions: Medtronic requests that you take the following actions: " Review your inventory for listed product. " Immediately identify and quarantine all unused, listed product in your inventory. " Return unused, listed product in your inventory to Medtronic by contacting Customer Service at 1-800-854-3570, Option 1 then Option 4, and referencing this communication to initiate a return and credit of unused product. Your Medtronic sales representative can assist you in the return of affected product as necessary. " Complete the enclosed Customer Confirmation Form and email to [email protected]. This form must be returned even if you do not have any affected product in your possession. " Please share this notification with others in your organization as appropriate. If product listed above has been forwarded to another facility, please notify the facility of this . " Please maintain a copy of this communication in your records. If you have any questions regarding this communication, please contact your Medtronic Field Representative.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0985-2025
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 22, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 22, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology